Novel crystalline form of 3-pyridyl-1-hydroxyethylidene-1,1-bisphopshonoc acid sodium salt
CZ20023575A3
Process for preparing N-ethyl-N-[3-(3-methyl-pyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-acetamide (zaleplon)
CZ293014B6
Process for preparing (-)-(S)-3-[1-(dimethylamino)ethyl]phenyl-N-ethyl-N-methyl carbamate
HU0400091A2
Method for preparation of antidiabetic pioglitazone
CZ2002383A3
Pharmaceutical preparation for treating acute pains
CZ291802B6
Process for preparing (R)-(-)-5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzene sulfonamide
CZ20012431A3
Process for preparing (4R,6R) tert-butyl[6-(2-aminoethyl)-2,2-dimethyl[1,3]dioxan-4-yl]acetate and intermediates for its preparation
CZ20011501A3
Process for preparing an intermediate for producing antidiabetic
CZ291364B6
Process for preparing antidiabetic
CZ289261B6
Tablet that can be produced by direct tabletting, containing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active compound and process for producing thereof
CZ279665B6
Preparation for treating injuries
CS701190A3
Preparation for the care of the skin in the form of an emulsion
CS631290A3
Antiviral gel
CS631190A3
E1 prostaglandin in injection medicinal form
CS593390A3
Antiphlogistic and antirheumatic compsn.
CS569890A3
Process for preparing 1-bromocyclopentyl-/2-chlorophenyl/-ketone
CS404890A3
General-purpose non-toxic printing ink for printing syringe ampoules
CS290590A3
Process for preparing water-soluble salts of heparin and derivatives thereof in extreme pure form
CS231590A3
Preparation for hemorrhoids treatment
CS275737B6
Process for obtaining insulin substance from extracts
